Prescribed drugs for drug misusers are usually dispensed by a community pharmacist (a High Street pharmacist). Anecdotal evidence has suggested that the management of drug misusers varies considerably between pharmacists. Furthermore, increased methadone prescribing in Scotland 1 has dramatically increased contact between drug misusers and pharmacists. This survey aimed to quantify the nature and extent of that contact.
Prescribing and pharmacists' provision of dispensing and other services to drug misusers has been quantified at a national level in England and Wales. 6, 7 This is the first such study in Scotland. It provides baseline information on pharmacists' current involvement in service provision, dispensing trends, attitudes and training.
Method
Content-setting, semi-structured interviews were held with community pharmacists to identify topics to be covered in a questionnaire. A questionnaire was then compiled including: demographic information, current involvement with drug misusers, training in drug misuse, attitudes to issues relating to drug misusers and willingness to participate in a follow-up telephone interview. Closed and open questions were used to gain factual information. The questionnaire was piloted in a random sample of 51 pharmacies, following which minor changes were made.
The questionnaire was sent to the remaining 1091 pharmacies in Scotland in October 1995. A reply-paid postcard was enclosed which responders were requested to return separately but at the same time as the questionnaire. Non-responders could then be identified while maintaining anonymity of the questionnaires. Two reminders were sent. This paper reports current prescribing and dispensing practice across Scotland. Attitudinal results are reported elsewhere. 8 
Results
A 79.2% (n = 864) response rate was achieved from the main questionnaire. Pilot questionnaire results were included (n = 894) where questions did not alter between the pilot and main questionnaire.
Drugs prescribed
Sixty-one per cent of all responders dispensed drugs for the management of drug misuse. Drugs dispensed were methadone (46%), diazepam (37%), dihydrocodeine (26%) and temazepam (25%). Other drugs dispensed by less than 5% of responders were nitrazepam, DHC Continus, chloral hydrate, buprenorphine, chlordiazepoxide, lofexidine and Diconal.
Methadone prescribing and dispensing
In total, 54.6% (n = 464) of pharmacies dispensed methadone, and there were 3387 methadone users, a rate of 0.66 methadone users per 1000 population in Scotland, as presented in Table 1 .
Family Practice-an international journal 376 There are 15 health boards in Scotland, but the responses from the three island health boards (Orkney, Shetland, Western Isles) were combined because numbers were so small.
Most prescriptions (74.6%) are written on form GP10 (equivalent of FP10 in England) by GPs as opposed to specialist clinics or hospitals. Sixty-five per cent of methadone dispensing is on a daily pick-up basis ( Fig. 1) .
Level of pharmacy involvement in methadone dispensing
Some pharmacists had considerable involvement with drug misusers, with an average of 7.3 methadone clients per pharmacy. Of the 464 pharmacists dispensing methadone at the time of the survey, 61.6% had one to five current clients, 29.9% had 6-20 current clients and 8.0% had over 20 current clients. (Current was defined as the number who had used that pharmacy for a methadone prescription in the past week.)
Pharmacy supervision of methadone consumption
Supervised consumption of methadone consumption varied considerably between health board areas (similar to Health Authorities); see Table 2 . Correspondingly, the current involvement and willingness of pharmacists in providing a supervised service varied as shown in Table 3 .
Methadone dispensing practice in pharmacies
Dispensing practices were quantified and results are presented in Table 4 .
Community pharmacy health promotion services to drug misusers Pharmacist provision of verbal or written health promotion information on drug misuse and HIV prevention to their drug misusing clients was extremely low (see Table 5 ).
Discussion
The high response rate to this postal questionnaire indicates the importance of this subject to pharmacists. Care of drug misusers in general practice has been encouraged 9,10 despite negative attitudes from GPs towards There are 15 health boards in Scotland but the responses from the three island health boards (Orkney, Shetland, Western Isles) were combined because numbers were so small. 4 undertaken at approximately the same time as this survey, found that methadone was similarly the most frequently prescribed drug. Amphetamine and diamorphine are prescribed in England and Wales. 7 In Scotland, 4.6% of new clients stated amphetamines as their main drug of use, 14 yet there was no evidence of prescribed amphetamines in this survey. Perhaps amphetamine prescriptions may be dispensed from other sources such as hospital pharmacies. Alternatively these results may reflect differences in services, with fewer private clinics in Scotland compared with England and/or differences in attitudes of professionals to prescribing for drug misuse.
Buprenorphine was formerly fairly widely misused in Scotland. This survey found dispensing of buprenorphine to be low, correlating with a low current prevalence of buprenorphine misuse. 14 This appears to be the result of increased control of buprenorphine prescribing.
There is evidence that prescribed methadone leaks onto the illicit market, 15 but this can be largely reduced by pharmacist supervision of methadone consumption, which has to be requested by the prescriber. Pharmacists are not contractually obliged to supervise methadone consumption. However, those not prepared to provide this service cannot dispense the prescription and must ensure that the drug misuser attends a pharmacy which will. 16 The proportion of methadone prescriptions dispensed daily and requiring supervision of consumption reflects management and prescribing priorities. Both varied considerably by health board area.
The reasons for the low rate of supervision, or even daily dispensed methadone in some areas, are unclear. In some areas with a known high prevalence of drug misuse, these were low. There may be a lack of guidance for GPs, concern for the privacy of the drug misuser or concern for the implications for pharmacists. Enforced supervision of methadone raises human rights issues, but these should be balanced against evidence that illicit Offer face-to-face advice on HIV prevention 2.6 28.0 69.4 methadone can be the first opioid used, 17 with the possibility of progression to injecting opioids. The role of community pharmacists in supervising methadone consumption must be considered carefully. Pharmacists in Glasgow are remunerated for this service and those in other areas more recently so. This may encourage more pharmacists to provide what can be a time-consuming service. 8 Another issue is privacy in the pharmacy. 18 Assistance from health boards with the construction of 'private areas' within pharmacies may encourage more pharmacists to provide this service, 8 although drug misusers do not necessarily want a private area but rather respect for their privacy. 18 Even if these issues are addressed, there is still a proportion of pharmacists who are unwilling to undertake this role. If the number of people prescribed methadone and requiring supervision of consumption increases, this may need to be addressed in order to prevent pharmacies currently providing this service from becoming overloaded.
It was common practice for pharmacists to establish ground rules with new methadone clients regarding times to collect prescriptions and general behaviour in the pharmacy, and to request identification. This is rarely done with other prescription clients, indicating that pharmacists treat drug misusers differently, despite what they believe. Written contracts were not widely used, perhaps because these are seen as a potentially confrontational practice. Such contracts for drug misusers are already used by prescribers (GPs and drug agency staff) and could be extended to involve pharmacists.
Provision of health promotion services to drug misusers is low. Further evidence from this survey (not reported here) indicates this may be because the appropriateness of giving such advice in a pharmacy is disputed. Many pharmacists see drug misusers frequently, and this is a good opportunity to pass on a number of important health promotion messages. Pharmacists should be encouraged, through training and local support, to develop health promotion services.
In summary, there is substantial variation in prescribing and dispensing practice across Scotland. The results are important for planning the future management of drug misusers and the control of substitute prescribing. Local prescribing policies and practice should be reviewed to determine whether prescribers need support or training. Given that training may be needed for both GPs and pharmacists, it would be feasible and desirable to undertake this jointly, promoting understanding and communication as well as providing a forum for addressing local issues. Community pharmacists have considerable contact with drug misusers, and pharmacy services should be refined to consolidate good practice with the appropriate support of health boards and local prescribers.
